| |
CABG
|
Valvular
|
P
|
|---|
|
Number
|
51
|
49
|
-
|
|
Age
|
64.65 ± 13.34
|
72.7 ± 10.4
|
0.106¶
|
|
Sex (Women, %)
|
8 (15.69%)
|
22 (44.89%)
|
0.001*
|
|
BMI (kg/m2)
|
26.91 ± 0.43
|
26.51 ± 0.57
|
0.5726§
|
|
EF (%)
|
62.51 ± 1.84
|
69.2 ± 1.41
|
0.006§
|
|
Tobacco
|
12 (23.53%)
|
9 (18.37%)
|
0.698*
|
|
Alcohol intake
|
15 (29.41%)
|
14 (28.57%)
|
0.898*
|
|
Hypertension
|
31 (60.78%)
|
27 (55.10%)
|
0.486*
|
|
Dyslipidemia
|
31 (60.78%)
|
16 (32.65%)
|
0.003*
|
|
Diabetes
|
24 (47.06%)
|
5 (10.20%)
|
< 0.001*
|
|
ACEI/ARB
|
25 (49.02%)
|
19 (38.77%)
|
0.302*
|
|
Beta blockers
|
16 (31.37%)
|
9 (18.37%)
|
0.133*
|
|
Calcium blockers
|
8 (15.69%)
|
10 (20.41%)
|
0.539*
|
|
Antiplatelet drugs
|
33 (64.71%)
|
8 (16.33%)
|
< 0.001*
|
|
Statins
|
34 (66.67%)
|
11 (22.45%)
|
< 0.001*
|
|
Nitrates
|
16 (31.37%)
|
2 (4.08%)
|
< 0.001*
|
|
Oral antidiabetics
|
16 (31.37%)
|
2 (4.08%)
|
< 0.001*
|
|
Insulin
|
13 (25.49%)
|
1 (2.04%)
|
< 0.001*
|
|
MI < 30 days
|
16 (31.37%)
|
0 (0%)
|
< 0.001*
|
|
EuroSCORE
|
3.6 ± 0.4194
|
5.7 ± 0.4
|
< 0.001*
|
- * = Chi-squared test, § = Student's t test, ¶ = U Mann-Whiney-Wilcoxon test
- BMI: body mass index; EF: ejection fraction; MI; myocardial infarction
